Primary |
Attention Deficit/hyperactivity Disorder |
50.0% |
Product Used For Unknown Indication |
20.6% |
Depression |
6.4% |
Drug Use For Unknown Indication |
4.4% |
Anxiety |
2.8% |
Insomnia |
2.1% |
Hypertension |
1.8% |
Asthma |
1.3% |
Seasonal Allergy |
1.3% |
Sleep Disorder |
1.3% |
Bipolar Disorder |
1.0% |
Chronic Fatigue Syndrome |
1.0% |
Gastrooesophageal Reflux Disease |
1.0% |
Hypersensitivity |
1.0% |
Hypothyroidism |
0.8% |
Post-traumatic Stress Disorder |
0.8% |
Supplementation Therapy |
0.8% |
Affective Disorder |
0.5% |
Autism |
0.5% |
Back Pain |
0.5% |
|
Weight Decreased |
15.0% |
Suicidal Ideation |
11.0% |
Off Label Use |
7.0% |
Overdose |
7.0% |
Product Substitution Issue |
7.0% |
Tic |
5.0% |
Convulsion |
4.0% |
Depression |
4.0% |
Drug Ineffective |
4.0% |
Hallucination |
4.0% |
Sudden Death |
4.0% |
Tachycardia |
4.0% |
Aggression |
3.0% |
Cleft Palate |
3.0% |
Mood Swings |
3.0% |
Product Quality Issue |
3.0% |
Suicide Attempt |
3.0% |
Tremor |
3.0% |
Unevaluable Event |
3.0% |
Urticaria |
3.0% |
|
Secondary |
Attention Deficit/hyperactivity Disorder |
35.5% |
Depression |
9.0% |
Product Used For Unknown Indication |
7.8% |
Anxiety |
7.0% |
Drug Use For Unknown Indication |
5.9% |
Bipolar Disorder |
4.7% |
Insomnia |
4.7% |
Sleep Disorder |
4.3% |
Somnolence |
3.9% |
Asthma |
3.5% |
Hypertension |
3.5% |
Obsessive-compulsive Disorder |
1.6% |
Off Label Use |
1.6% |
Affective Disorder |
1.2% |
Fibromyalgia |
1.2% |
Mineral Supplementation |
1.2% |
Narcolepsy |
1.2% |
Arthralgia |
0.8% |
Asthenia |
0.8% |
Barrett's Oesophagus |
0.8% |
|
Drug Exposure During Pregnancy |
11.5% |
Hallucination |
11.5% |
Weight Decreased |
8.2% |
Cerebrovascular Accident |
6.6% |
Off Label Use |
6.6% |
Urinary Incontinence |
6.6% |
Mood Swings |
4.9% |
Product Substitution Issue |
4.9% |
Aggression |
3.3% |
Anxiety |
3.3% |
Drug Dispensing Error |
3.3% |
Drug Effect Decreased |
3.3% |
Fatigue |
3.3% |
Hepatic Enzyme Increased |
3.3% |
Hyperhidrosis |
3.3% |
Inappropriate Schedule Of Drug Administration |
3.3% |
Overdose |
3.3% |
Pollakiuria |
3.3% |
Product Quality Issue |
3.3% |
Sarcoidosis |
3.3% |
|
Concomitant |
Attention Deficit/hyperactivity Disorder |
15.8% |
Product Used For Unknown Indication |
14.6% |
Depression |
11.2% |
Contraception |
7.0% |
Bipolar Disorder |
6.1% |
Pain |
5.9% |
Drug Use For Unknown Indication |
5.1% |
Multiple Sclerosis |
5.1% |
Anxiety |
3.9% |
Acne |
3.4% |
Premenstrual Syndrome |
3.0% |
Hypertension |
2.8% |
Headache |
2.3% |
Arthritis |
2.1% |
Crohn's Disease |
2.0% |
Migraine |
2.0% |
Gastrooesophageal Reflux Disease |
1.9% |
Hypersensitivity |
1.9% |
Sleep Disorder |
1.9% |
Smoking Cessation Therapy |
1.8% |
|
Pulmonary Embolism |
8.4% |
Weight Decreased |
8.4% |
Weight Increased |
8.4% |
Suicidal Ideation |
7.0% |
Vomiting |
7.0% |
Injury |
6.3% |
Viral Pharyngitis |
5.6% |
Nausea |
4.9% |
Rash |
4.9% |
Fatigue |
4.2% |
Tremor |
4.2% |
Drug Ineffective |
3.5% |
Gallbladder Disorder |
3.5% |
Insomnia |
3.5% |
Multiple Sclerosis Relapse |
3.5% |
Myalgia |
3.5% |
Pain |
3.5% |
Tic |
3.5% |
White Blood Cell Count Decreased |
3.5% |
Anxiety |
2.8% |
|
Interacting |
Attention Deficit/hyperactivity Disorder |
25.9% |
Smoking Cessation Therapy |
18.5% |
Disturbance In Attention |
14.8% |
Anxiety |
7.4% |
Ex-smoker |
7.4% |
Ex-tobacco User |
7.4% |
Pain |
7.4% |
Affective Disorder |
3.7% |
Depression |
3.7% |
Muscle Spasms |
3.7% |
|
Vomiting |
44.4% |
Drug Interaction |
22.2% |
Irritability |
11.1% |
Therapeutic Response Unexpected |
11.1% |
Tic |
11.1% |
|